A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
08/1999
08/18/1999	EP0935467A1 Compounds that inhibit interaction between signal-transducing proteins and the glgf (pdz/dhr) domain and uses thereof
08/18/1999	EP0935464A1 Inhibitors of farnesyl-protein transferase
08/18/1999	EP0935458A1 Compositions containing at least one nucleic acid
08/18/1999	EP0935415A1 Methods for delivering compounds into a cell
08/18/1999	EP0896537B1 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide
08/18/1999	EP0792292B1 Orphan receptor
08/18/1999	EP0722332B1 Treatment of precancerous lesions by muramyl peptides
08/18/1999	EP0643726B1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
08/18/1999	CN1226254A Method and composition useful for inhibition of vasculogenesis of alpha, beta medium
08/18/1999	CN1226249A Substituted bisindolylmaleimides for inhibition of cell proliferation
08/18/1999	CN1226248A Substituted bisindolylmaleimides for inhibition of cell proliferation
08/18/1999	CN1226247A Substituted bisindolyl maleimides for inhibition of cell proliferation
08/18/1999	CN1226246A Noval tricyclic N-cyanoimines useful as inhibitors of farnesyl-protein transferase
08/18/1999	CN1226232A Acryloyl substituted distamycin derivative, process for preparing them, and use as antitumor and antiviral agents
08/18/1999	CN1226172A Method and compositions useful for inhibiting angiogenesis
08/18/1999	CN1226171A Type-2 chemokine binding proteins and methods of use thereof
08/18/1999	CN1226148A Method for improving selectivity in photo-activation of molecular agents
08/17/1999	US5939583 Antiarthritic agents; bone, cardiovascular, brain, nervous system disorders; antitumor and antimetastasis agents
08/17/1999	US5939567 Reacting stoiochiometric amount of fatty acid chloride or anhydride with taxane to attach the hydrocarbon chain to the hydroxy group at position 2' of taxane
08/17/1999	US5939560 Inhibitors of DP-mediated processes, compositions and therapeutic methods thereof
08/17/1999	US5939527 Tetrapeptides as antitumor agents
08/17/1999	US5939449 Novel compounds having high affinity for the neurotensin receptors
08/17/1999	US5939420 Pyrrolo 2,3d!derivatives
08/17/1999	US5939416 Inhibit ras function, use for treating tumor cells expressing an activated ras oncogene in mammals
08/17/1999	US5939402 Treating plasmodium, viral infections or parasites in mammals
08/17/1999	US5939391 Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
08/17/1999	US5939286 Hybrid interferon tau/alpha polypeptides, their recombinant production, and methods using them
08/12/1999	WO1999040220A2 Method of screening therapeutic agents
08/12/1999	WO1999040207A1 HUMAN HEPARANASE POLYPEPTIDE AND cDNA
08/12/1999	WO1999040201A1 Protein
08/12/1999	WO1999040188A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccinations
08/12/1999	WO1999040187A1 Nucleic acids provided for modulating cellular activation
08/12/1999	WO1999040186A1 Optimized antisense oligonucleotides complementary to dna methyltransferase sequences
08/12/1999	WO1999040185A1 Cytotoxic heteromeric protein combinatorial libraries
08/12/1999	WO1999040184A1 Dendritic enriched secreted lymphocyte activation molecule
08/12/1999	WO1999040183A1 Human serine protease and serpin polypeptides
08/12/1999	WO1999040119A1 Monoclonal antibody which recognizes the oligosaccharide n-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it
08/12/1999	WO1999040110A1 Breast cancer resistance protein (bcrp) and the dna which encodes it
08/12/1999	WO1999040099A1 5'-deoxycytidine derivatives
08/12/1999	WO1999040091A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
08/12/1999	WO1999040089A1 Benzothiadiazoles and derivatives
08/12/1999	WO1999040088A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors
08/12/1999	WO1999040080A1 Hydroxamic and carboxylic acid derivatives
08/12/1999	WO1999040069A1 Benzyloxy prodigiosine compounds
08/12/1999	WO1999040064A1 Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
08/12/1999	WO1999040056A1 Hydroxylation activated prodrugs
08/12/1999	WO1999039746A2 Radioactive seed implants
08/12/1999	WO1999039741A2 Systemic delivery of serum stable plasmid lipid particles for cancer therapy
08/12/1999	WO1999039740A2 Sensitizing cells to compounds using lipid-mediated gene and compound delivery
08/12/1999	WO1999039702A2 Method for regulating size and growth of vascularized normal tissue
08/12/1999	WO1999039694A2 Compositions containing organic compounds
08/12/1999	WO1999028304A3 Pdgf receptor kinase inhibitory compounds, their preparation and compositions
08/12/1999	WO1999027955A3 Treatment of established chronic infections and cancers
08/12/1999	WO1999027919A3 Cyp2a enzymes and their use in therapeutic and diagnostic methods
08/12/1999	WO1999025378A9 Immunoglobulin molecules having a synthetic variable region and modified specificity
08/12/1999	WO1999018195A3 Methods and compositions for inducing tumor-specific cytotoxicity
08/12/1999	WO1999015684A8 Expression of genes in hematopoietic stem cells in hischaemic conditions
08/12/1999	WO1999004820A3 Cytolysis of target cells by superantigen conjugates inducing t-cell activation
08/12/1999	WO1999002143A3 Medicament comprising adenosine
08/12/1999	WO1999000116A3 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
08/12/1999	WO1998057662A3 Therapeutic systems
08/12/1999	WO1998049146A3 Cyclin dependent kinase (cdk)4 inhibitors and their use for treating cancer
08/12/1999	WO1998008505A8 Pharmaceutical compounds
08/12/1999	DE19803453A1 Vakzine Vaccine
08/12/1999	CA2321175A1 Method of screening therapeutic agents
08/12/1999	CA2321025A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors
08/12/1999	CA2319644A1 Human serine protease and serpin polypeptides
08/12/1999	CA2319555A1 Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
08/12/1999	CA2319468A1 Sensitizing cells to compounds using lipid-mediated gene and compound delivery
08/12/1999	CA2319248A1 Radioactive seed implants
08/12/1999	CA2319097A1 Dendritic enriched secreted lymphocyte activation molecule
08/12/1999	CA2319086A1 Optimized antisense oligonucleotides complementary to dna methyltransferase sequences
08/12/1999	CA2318977A1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines
08/12/1999	CA2317476A1 Hydroxamic and carboxylic acid derivatives
08/12/1999	CA2286174A1 Benzyloxy prodigiosine compounds
08/11/1999	EP0935000A2 Orphan receptor
08/11/1999	EP0934931A2 3-Benzylidene-2-indolinones and their analogues as tyrosine kinase activity modulators
08/11/1999	EP0934746A1 Substance in the form of an aqueous extract of vegetal raw material for treating oncological diseases, and method for producing the same
08/11/1999	EP0934413A1 Placental-derived prostate growth factors
08/11/1999	EP0934412A1 HUMAN THYMOSIN beta 15 GENE, PROTEIN AND USES THEREOF
08/11/1999	EP0934410A1 Brain-associated inhibitor of tissue-type plasminogen activator
08/11/1999	EP0934405A1 Melanoma associated peptide analogues and vaccines against melanoma
08/11/1999	EP0934404A1 Inhibition of proliferation of cells
08/11/1999	EP0934403A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation
08/11/1999	EP0934333A1 Unique associated kaposi's sarcoma virus sequences and uses thereof
08/11/1999	EP0934331A2 Mirror-symmetrical selection and evolution of nucleic acids
08/11/1999	EP0934329A1 Glycoconjugates from modified camptothecin derivates (20-o-linkage)
08/11/1999	EP0934325A1 Tetraphosphonate bicyclic trisanhydrides
08/11/1999	EP0934318A1 Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
08/11/1999	EP0934317A2 Novel 6 or 7 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
08/11/1999	EP0934309A1 New pyridyl alkane acid amides as cytostatics and immunosuppressives
08/11/1999	EP0934307A1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
08/11/1999	EP0934305A1 Integrin antagonists
08/11/1999	EP0934303A2 Compounds useful for inhibition of farnesyl protein transferase
08/11/1999	EP0934300A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
08/11/1999	EP0934297A1 NOVEL $i(cis)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
08/11/1999	EP0934292A1 Metalloproteinase inhibitors
08/11/1999	EP0934278A1 Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents
08/11/1999	EP0934277A1 Process for the preparation of n- 2-(dimethylamino)ethyl]acridine-4-carboxamide
08/11/1999	EP0934276A1 Anthranilic acid derivatives as multi drug resistance modulators

1 ... 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 ... 2211